Sepsis Diagnostics Market Ravishing CAGR 9.2% to Hit US$ 1,226.52 million by 2028| Global Analysis by The Insight Partners

According to our latest study on "Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Technology, Method, Test Type, Pathogen, and End User," the market is expected to grow from US$ 661.83 million in 2021 to US$ 1,226.52 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments.

Sepsis is a serious and life-threatening clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. Three stages of sepsis are sepsis, severe sepsis, and the final stage of septic shock. Sepsis diagnostics is the study of diagnosis of this condition.

Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Hospital-acquired infections, also known as nosocomial infections, are the primary cause of morbidity and mortality among hospitalized patients.

Get Sample PDF Copy of Sepsis Diagnostics Market at:
https://www.theinsightpartners.com/sample/TIPHE100001391/?utm_source=OpenPR&utm_medium=10411

Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients.

Based on product, the global sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. In 2021, the blood culture media segment held the largest share of the market. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points towards further investigations for identifying the focus on infection.

As per end-user, the global sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. In 2021, the hospital's segment held the largest share of the market. However, the pathology and reference laboratories segment is expected to register the highest CAGR in the market during the forecast period.

Some well-established companies influencing global Sepsis Diagnostics market trends are: Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher; Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; T2 Biosystems, Inc.; and Axis-Shield Diagnostics Ltd are among the leading companies operating in the sepsis diagnostics market growth.

Have Question? Speak to Analyst at:
https://www.theinsightpartners.com/speak-to-analyst/TIPHE100001391/?utm_source=OpenPR&utm_medium=10411

Sepsis Diagnostics - Market Segmentation
The global sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end-user. In terms of product, the global sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. Based on technology, the sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. In terms of method, the market is segmented into automated diagnostics and conventional diagnostics. Based on test type, the global sepsis diagnostics market is segmented into point-of-care tests and laboratory tests. In terms of the pathogen, the market is segmented into bacteria sepsis, fungal sepsis, and others. In terms of end-user, the sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others.

Essential points covered in the Sepsis Diagnostics market report are:-
1 What will the market size and the growth rate be in 2028?
2 What are the key growth stimulants of the Sepsis Diagnostics market?
3 What are the key market trends impacting Sepsis Diagnostics market valuation?
4 What are the challenges to market proliferation?
5 Who are the key vendors in the Sepsis Diagnostics market?
6 Which are the leading companies contributing to Sepsis Diagnostics market valuation?
7 What was the market share held by each region in 2028?
8 What is the estimated growth rate and valuation of Sepsis Diagnostics market in 2028 ?

Order a Copy of Sepsis Diagnostics Market Share, Strategies and Forecasts 2021-2028 Research Report at:
https://www.theinsightpartners.com/buy/TIPHE100001391/?utm_source=OpenPR&utm_medium=10411

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.